Objective-To study the association between coxsackie B virus infection and the postviral fatigue syndrome and to assess the immunological abnormalities associated with the syndrome.
Design-Case-control study of patients with the postviral fatigue syndrome referred by local general practitioners over one year.
Setting-General practitioner referrals in Dunbartonshire, Scotland.
Patients-254 Patients referred with the postviral fatigue syndrome (exhaustion, myalgia, and other symptoms referable to postviral fatigue syndrome of fairly recent onset-that is, several months) and age and sex matched controls obtained from same general practitioner; 11 patients were rejected because of wrong diagnoses, resolution of symptoms, and refusal to participate, leaving 243 patients and matched controls.
Main outcome measures-Detailed questionnaire (patients and controls) and clinical examination (patients) and blind analysis of blood sample at entry and after six months for determination of coxsackie B 
Laboraton-investigations
Blood obtained from patients and matched controls (usually within one month of each other) was tested blind for coxsackie virus IgM antibodies using the mu-antibody-capture enzyme linked immunosorbent assay (ELISA) test" and for coxsackie B virus IgG neutralising antibodies with the micrometabolic inhibition method,'2 at entry and after six months. A full blood count, renal and hepatic function tests, and virological screen were done in all patients at entry.
Immunological studies
In vitro peripheral blood lymphocyte protein synthesis, lymphocyte subset analysis, and immune complexes' were determined in 35 randomly selected patients and 35 controls as well as immunoglobulin estimations in the 35 controls and 227 study patients.
Statistical methods
The Although there has been much interest and discussion regarding the role of immune dysfunction in the aetiology of the postviral fatigue syndrome, few consistent immunological abnormalities have been reported. Reports have included abnormal circulating lymphocytes and depressed lymphocyte function with impaired cytotoxic T cell responses to specific virus epitopes,'5 increased or decreased immunoglobulin concentrations,'6 immune complexes containing coxsackie B virus antigen,'7 and normal and abnormal suppressor and inducer T cell counts. 16 18 Until now, no reports of reduced B and NK cell counts have been published. Discrepancies in lymphocyte subpopulations seen in different studies are also found in other disease states such as multiple sclerosis'9 and may reflect differences in technique, selection of patients, and sampling criteria. Although not specifically designed to investigate the role of immune dysfunction in the aetiology of the postviral fatigue syndrome, our study does throw some doubt on the usefulness of these immunological variables in diagnosing this condition in so far as individual controls often had appreciably abnormal results of one or more of the immunological variables, including T cell subsets, protein synthesis, and complement concentrations. In particular, the raised immune complex and total IgM concentrations found in this study may simply reflect the background exposure of the population to coxsackie B virus. An association between coxsackie B virus infection and the postviral fatigue syndrome has been noted in some studies5'9 but not others,20"2 and other causative agents have been incriminated in yet other studies." 16 18 22-25 Newer Main outcome measures-Serum sialic acid concentration, serum cholesterol concentration, diastolic blood pressure, body mass index at the general health survey visit; cardiovascular and noncardiovascular deaths during three periods of foliow up (0-6 years, 7-13 years, and 14-20 years), according to the Swedish mortality register, in subjects aged 45-74.
Results-Mean serum sialic acid concentration (mg/100 ml) was 68*8 (SD 8.0) for men and 69-2 (8.0) for women; the average concentration increasing with age in both sexes. A total of 5639 (21%) men and 3307 (12%) women died during the follow up period, in whom death in 3052 (54%) men and 1368 (41%) women was from cardiovascular causes. During short (0-6 years), medium (7-13 years), and long (14) (15) (16) (17) (18) (19) (20) years) term follow up the relative risk of death from cardiovascular disease increased with increasing serum sialic acid concentration. The relative risk (95% confidence interval) associated with the highest quartile of sialic acid concentration compared with the lowest quartile was 2-38 (2-01 to 2.83) in men and (1-93 to 3.57) in women.
Similar results were found for deaths from noncardiovascular disease with relative risks of 1-50 (1.34 to 2.68) in men and 1X89 (1.57 to 2.28) in women, but these relative risks were significantly lower than those for deaths from cardiovascular disease (p<0-001 and p<0005 respectively). In multivariate analysis of total mortality and of cardiovascular mortality with sialic acid concentration, serum cholesterol concentration, diastolic blood pressure, and body mass index as independent variables the impact of sialic acid concentration was virtually the same as in univariate analysis.
Conclusion-Serum sialic acid concentration is a strong predictor of cardiovascular mortality. A possible explanation of these findings is that the serum sialic acid concentration may reflect the existence or the activity of an atherosclerotic process, and this may warrant further investigation.
Introduction
Sialic acid, a family of acetylated derivatives of neuraminic acid, is widely distributed in mammals. It usually occurs as a terminal component at the nonreducing end of carbohydrate chains of glycoproteins BMJ VOLUME 302
